Blood Journal | Cdk4 and Cdk6 cooperate in counteracting the INK4 family of inhibitors during murine leukemogenesis

Blood Journal | Cdk4 and Cdk6 cooperate in counteracting the INK4 family of inhibitors during murine leukemogenesis

Cdk4 and Cdk6 cooperate in counteracting the INK4 family of inhibitors during murine leukemogenesis

1. Esther Rodríguez-Díez1, 
2. Victor Quereda1, 
3. Florian Bellutti2, 
4. Michaela Prchal-Murphy2, 
5. David Partida1, 
6. Manuel Eguren1, 
7. Karoline Kollmann2, 
8. Marta Gómez de Cedrón1, 
9. Pierre Dubus3, 
10. Marta Cañamero4, 
11. Dolores Martínez5, 
12. Veronika Sexl2, and 
13. Marcos Malumbres1

Author Affiliations

• Article
• Figures & Data
• Info & Metrics
• E-Letters
• PDF

Key Points

• A Cdk6 R31C knock-in mutation resistant to INK4 inhibitors cooperates with Cdk4 hyperactivity in the development of hematopoietic tumors.
• In Cdk6 R31C cells, p16INK4a increasingly binds and inhibits Cdk4, suggesting that both kinases cooperate in sequestering INK4 proteins in cancer.

Abstract

Cdk4 and Cdk6 are related protein kinases that bind D-type cyclins and regulate cell-cycle progression. Cdk4/6 inhibitors are currently being used in advanced clinical trials and show great promise against many types of tumors. Cdk4 and Cdk6 are inhibited by INK4 proteins, which exert tumor-suppressing functions. To test the significance of this inhibitory mechanism, we generated knock-in mice that express a Cdk6 mutant (Cdk6 R31C) insensitive to INK4-mediated inhibition. Cdk6R/R mice display altered development of the hematopoietic system without enhanced tumor susceptibility, either in the presence or absence of p53. Unexpectedly, Cdk6 R31C impairs the potential of hematopoietic progenitors to repopulate upon adoptive transfer or after 5-fluorouracil–induced damage. The defects are overcome by eliminating sensitivity of cells to INK4 inhibitors by introducing the INK4-insensitive Cdk4 R24C allele, and INK4-resistant mice are more susceptible to hematopoietic and endocrine tumors. In BCR-ABL–transformed hematopoietic cells, Cdk6 R31C causes increased binding of p16INK4a to wild-type Cdk4, whereas cells harboring Cdk4 R24C and Cdk6 R31C are fully insensitive to INK4 inhibitors, resulting in accelerated disease onset. Our observations reveal that Cdk4 and Cdk6 cooperate in hematopoietic tumor development and suggest a role for Cdk6 in sequestering INK4 proteins away from Cdk4.

• Submitted February 11, 2014.
• Accepted August 7, 2014.

• © 2014 by The American Society of Hematology